Peter Stephen Keen
Directeur/Membre du Conseil chez Lifearc
Profil
Peter Stephen Keen is the founder of Excalibur Fund Managers Ltd.
(1996), Ark Therapeutics Group Plc (1997), and Chiroscience Group Plc (1992).
He is currently a Director at Endomagnetics Ltd., a Director at SpringWorks Therapeutics LLC, and a Trustee at Lifearc.
Mr. Keen's former positions include Chief Executive Officer at Cambridge Innovation Capital Ltd (2013-2015), Chairman at Oval Medical Technologies Ltd., Director at Vectura Group Ltd., Director at ReNeuron Group Plc, Senior Independent Non-Executive Director at Abcam Plc (2010-2014), Director at Prelude Trust Plc (2007-2009), Independent Non-Executive Director at The Biotech Growth Trust Plc (2013-2017), Board Member & Finance Director at Serentis Ltd.
(2010), Director at Exosect Ltd., Non-Executive Director at Horizon Discovery Ltd., Director at Cyclacel Ltd., Non-Executive Director at Congenica Ltd., Independent Non-Executive Director at HealthCare Royalty Trust PLC, Chief Financial Officer at BioProgress Plc, Principal at The MicroBio Group Ltd., Chief Financial Officer at Sosei R&D Ltd.
(2004-2006), Partner at Molten Ventures (Private Equity) (2006-2007), and Member-Supervisory Board at Kiadis Pharma BV.
Keen received an undergraduate degree from The University of Hull.
Postes actifs de Peter Stephen Keen
| Sociétés | Poste | Début |
|---|---|---|
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/02/2013 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Directeur/Membre du Conseil | - |
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 23/02/2017 |
Anciens postes connus de Peter Stephen Keen
| Sociétés | Poste | Fin |
|---|---|---|
| THE BIOTECH GROWTH TRUST PLC | Directeur/Membre du Conseil | 12/07/2017 |
| ABCAM PLC | Directeur/Membre du Conseil | 03/11/2014 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Fondateur | 12/03/2012 |
Serentis Ltd.
 Serentis Ltd. Pharmaceuticals: MajorHealth Technology Serentis Ltd. discovered, developed and distributed pharmaceutical products. The company was founded by Tim Sharpington, Alan Rothaul, and Andy Baxter in 2006 and was headquartered in London, the United Kingdom. | Directeur Financier/CFO | 01/03/2010 |
Prelude Trust Plc
 Prelude Trust Plc Investment ManagersFinance Prelude Trust Plc invests in technology and life science companies located in the UK. It targets companies operating in the fields of information technology, communications, advanced materials, sensors, displays & semiconductors, healthcare, drug discovery and medical devices. It provides financing for seed and early stage capital requirements. | Directeur/Membre du Conseil | 18/06/2009 |
Formation de Peter Stephen Keen
| The University of Hull | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABCAM PLC | Health Technology |
| RENEURON GROUP PLC | Health Technology |
| Entreprise privées | 22 |
|---|---|
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
| BioProgress Plc | Commercial Services |
Molten Ventures (Private Equity)
 Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Finance |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Finance |
Prelude Trust Plc
Prelude Trust Plc Investment ManagersFinance Prelude Trust Plc invests in technology and life science companies located in the UK. It targets companies operating in the fields of information technology, communications, advanced materials, sensors, displays & semiconductors, healthcare, drug discovery and medical devices. It provides financing for seed and early stage capital requirements. | Finance |
The Biotech Growth Trust Plc
 The Biotech Growth Trust Plc Investment Trusts/Mutual FundsMiscellaneous The Biotech Growth Trust Plc is a closed-end investment trust. Its objective is to seek capital through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies. The company was founded on May 20, 1997 by Christopher Thomas Evans and is headquartered in London, the United Kingdom. | Miscellaneous |
The MicroBio Group Ltd.
 The MicroBio Group Ltd. Chemicals: AgriculturalProcess Industries Microbio Group Ltd. manufactures organic fertilizers and crop protection products. The company is headquartered in Littlehampton, GB. | Process Industries |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Exosect Ltd.
 Exosect Ltd. Miscellaneous Commercial ServicesCommercial Services Exosect Ltd. develops and provides pest management solutions. It enables pesticide manufacturers to improve the delivery of their formulations to overcome pest resistance, regulatory control and residues within the food chain. The firm offers Entostat delivery platform an electro statically charged micro powder that is formulated to microencapsulate synthetic active ingredients and Entomag delivery platform, a ferrous micro powder that enables the particle to be held in place to a suitable magnetic device and used to the targeted delivery of synthetic chemistry particularly for the control of crawling insects in the public health sector. It serves the agriculture, public health and animal health sectors. The company was founded by Philip Harris on April 29, 1999 and is headquartered in Winchester, the United Kingdom. | Commercial Services |
| Chiroscience Group Plc | Commercial Services |
Serentis Ltd.
Serentis Ltd. Pharmaceuticals: MajorHealth Technology Serentis Ltd. discovered, developed and distributed pharmaceutical products. The company was founded by Tim Sharpington, Alan Rothaul, and Andy Baxter in 2006 and was headquartered in London, the United Kingdom. | Health Technology |
Oval Medical Technologies Ltd.
 Oval Medical Technologies Ltd. Medical SpecialtiesHealth Technology Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Kiadis Pharma BV
 Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
| Cyclacel Ltd. | |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Finance |
HealthCare Royalty Trust PLC
 HealthCare Royalty Trust PLC Investment Trusts/Mutual FundsMiscellaneous HealthCare Royalty Trust PLC is a closed-ended investment fund which intended to establish one or more wholly-owned subsidiaries for efficient portfolio management. The company was founded on December 15, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Health Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
